Toxicity and Therapy of Cisplatin-Loaded Egf Modified Mpeg-Plga-Pll Nanoparticles for Skov3 Cancer in Mice

Yunfei Wang,Peifeng Liu,Lihua Qiu,Ying Sun,Mingjie Zhu,Liying Gu,Wen Di,Yourong Duan
DOI: https://doi.org/10.1016/j.biomaterials.2012.12.033
IF: 14
2013-01-01
Biomaterials
Abstract:Construction on the nanoparticles with lower toxicity and specific tumor targeting properties is challenging and requires careful design of composition, size, physicochemical properties tailored for the nanoparticles. Here the epidermal growth factor (EGF) modified methoxy polyethylene glycol-polylactic-co-glycolic acid-polylysine (mPEG-PLGA-PLL) encapsulated cisplatin (CDDP) nanoparticles (CDDP-NPs-EGF) was prepared to for solving the toxicity of CDDP and improving therapeutic efficiency. The remarkable features of CDDP-NPs-EGF are increasing cytotoxicity that attribute to effective cell cycle arrest and high cell apoptosis in vitro. In vivo, the CDDP-NPs-EGF change drug distribution, decrease the nephrotoxicity of CDDP and improve significantly therapeutic efficiency without inducing obvious system toxicity, verifying its key role of the CDDP-NPs-EGF in lowering drug toxicity and enhancing the antitumor efficiency for SKOV3 cancer in mice.
What problem does this paper attempt to address?